Patents by Inventor Nirmalya Ganguli

Nirmalya Ganguli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140351966
    Abstract: The present invention relates to a new method of gene integration in cells comprising the steps of: preparation of a suspension of poly nucleotide fragments comprising the desired gene in a hypotonic solution; administration of said suspension to cells or tissues; and maintenance of the cells or tissues in vitro or in its normal physiological condition. The invention also relates to a method of generating transgenic animal.
    Type: Application
    Filed: December 4, 2013
    Publication date: November 27, 2014
    Applicant: National Institute of Immunology
    Inventors: Subeer Suhash Majumdar, Abul Usmani, Nirmalya Ganguli
  • Publication number: 20130245228
    Abstract: The present invention relates to a method of in vitro isolation of buffalo ?-caesin promoter (buCSN2) along with the regions exon1, intron1 and exon2 from the genomic DNA in vitro (Bubalus bubalis) and its functional activity in using mammary cell line. The novel buffalo ?-caesin promoter along with exon1, intron1 and exon2 is isolated and cloned upstream of the Enhanced Green flourescence protein (EGFP) gene and sequenced. The transfection of the DNA construct resulted into production of EGFP protein in mammary cell lines, confirming bioactivity of this newly isolated buffalo promoter sequence. More specifically, the present invention relates to isolation, cloning, sequencing and functional analysis of the buffalo ?-casein promoter in vitro using mammary cell line.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 19, 2013
    Applicant: National Institute of Immunology
    Inventors: Subeer Suhash Majumdar, Nirmalya Ganguli, Abul Usmani
  • Publication number: 20120264814
    Abstract: The present invention relates to a method of in vitro isolation of buffalo ?-caesin promoter (buCSN2) along with the regions of exon1, intron1 and exon2 from the genomic DNA in vitro (Bubalus bubalis) and its functional activity in using mammary cell line. The novel buffalo ?-caesin promoter along with exon1, intron1 and exon2 is isolated and cloned upstream of the Enhanced Green flourescence protein (EGFP) gene and sequenced. The transfection of the DNA construct resulted into production of EGFP protein in mammary cell lines, confirming bioactivity of this newly isolated buffalo promoter sequence. More specifically, the present invention relates to isolation, cloning, sequencing and functional analysis of the buffalo ?-casein promoter in vitro using mammary cell line.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 18, 2012
    Applicant: NATIONAL INSTITUTE OF IMMUNOLOGY
    Inventors: Subeer Suhash MAJUMDAR, Nirmalya Ganguli, Abul Usmani